We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$538M
AUM Growth
+$20.3M
Cap. Flow
+$44.8M
Cap. Flow %
8.33%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
HOWL icon
Werewolf Therapeutics
HOWL
+$58.7M

Top Sells

Rank Stock Value
1
RPTX
Repare Therapeutics
RPTX
+$10.9M
2
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$2.06M
3
ITOS
iTeos Therapeutics
ITOS
+$974K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
1
Dyne Therapeutics
DYN
$4.53B
$104M 19.37%
4,951,303
– –
ITOS
2
DELISTED
iTeos Therapeutics
ITOS
$94M 17.48%
3,665,787
-40,876
-1% -$974K
HOWL icon
3
Werewolf Therapeutics
HOWL
$47M
$74.7M 13.89%
+4,284,172
New +$58.7M
RPTX
4
DELISTED
Repare Therapeutics
RPTX
$70.8M 13.17%
2,271,177
-331,912
-13% -$10.9M
TCRR
5
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$66.5M 12.36%
4,050,865
– –
HARP
6
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$43.4M 8.07%
313,027
-10,804
-3% -$2.06M
ONCR
7
DELISTED
Oncorus, Inc.
ONCR
$39.3M 7.31%
2,849,464
– –
CHMA
8
DELISTED
Chiasma, Inc. Common Stock
CHMA
$27.1M 5.04%
5,736,296
– –
RYTM icon
9
Rhythm Pharmaceuticals
RYTM
$7.07B
$17.8M 3.31%
909,258
– –

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, MPM Asset Management held 9 positions worth $538M, up 3.9% from $518M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management deployed $44.8M of net new capital in Q2 2021, opening 1 new position. Its largest new stake was Werewolf Therapeutics: 4,284,172 shares worth $74.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Repare Therapeutics, an estimated $10.9M trimmed.

  • MPM Asset Management's largest Q2 2021 buy was Werewolf Therapeutics: 4,284,172 shares worth $74.7M.
  • MPM Asset Management's biggest Q2 2021 reduction was Repare Therapeutics, cutting an estimated $10.9M.
  • MPM Asset Management's ten largest holdings make up 100% of its $538M portfolio in Q2 2021.
  • MPM Asset Management opened 1 new position and closed 0 in Q2 2021.
  • MPM Asset Management's portfolio value rose 3.9% quarter-over-quarter to $538M.

Based on MPM Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.